OOIR: Observatory of International Research

Papers

(The TQCC of Progress in Retinal and Eye Research is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Widefield OCT angiography	261
The neuroimmune interface in retinal regeneration	156
In vivo application of base and prime editing to treat inherited retinal diseases	146
Cell identity changes in ocular surface Epithelia	143
Animal models for the evaluation of retinal stem cell therapies	138
Phenotyping and genotyping FEVR: Molecular genetics, clinical and imaging features, and therapeutics	114
International consensuses and controversies on causes, diagnosis and management of diabetic macular edema (DME)	111
Non-vasogenic cystoid maculopathies	110
Editorial Board	108
Consensus and controversies in the science of endophthalmitis management: Basic research and clinical perspectives	105
Central serous chorioretinopathy: An evidence-based treatment guideline	100
Unravelling CYP4V2: Clinical features, genetic insights, pathogenic mechanisms and therapeutic strategies in Bietti crystalline corneoretinal dystrophy	99
Mitophagy in the retina: Viewing mitochondrial homeostasis through a new lens	98
The impact of sensory neuropathy and inflammation on epithelial wound healing in diabetic corneas	97
Corneal stromal repair and regeneration	96
Structure and function of ABCA4 and its role in the visual cycle and Stargardt macular degeneration	89
Editorial Board	86
A paradigm shift in retinal detachment repair: The concept of integrity	83
Homeostatic plasticity in the retina	79
Squishy matters – Corneal mechanobiology in health and disease	78
Etiopathogenesis of primary acquired nasolacrimal duct obstruction (PANDO)	77
Photocoagulation for retinal vein occlusion	74
Myocilin misfolding and glaucoma: A 20-year update	73
Gene-independent therapeutic interventions to maintain and restore light sensitivity in degenerating photoreceptors	72
The endoplasmic reticulum: Homeostasis and crosstalk in retinal health and disease	70

Risk factors, clinical features and treatment of Behçet's disease uveitis	70
Cell fate decisions, transcription factors and signaling during early retinal development	70
Editorial Board	69
RNA-targeting strategies as a platform for ocular gene therapy	69
Protection against corneal hyperosmolarity with soft-contact-lens wear	67
Genetic architecture of congenital cataracts: correlation of pathogenic variants with morphology and clinical outcomes	66
How gut microbiota may impact ocular surface homeostasis and related disorders	66
The retinal pigmentation pathway in human albinism: Not so black and white	66
Approaches for corneal endothelium regenerative medicine	64
Multiple gene therapy as a tool for regulating the expression of molecules involved in neovascular age-related macular degeneration	64
Corrigendum to “Optical coherence tomography in the management of diabetic macular oedema” [Prog. Retin. Eye Res. 98 (2024) 101220]	64
Cellular component transfer between photoreceptor cells of the retina	63
Exploring single-cell RNA sequencing as a decision-making tool in the clinical management of Fuchs’ endothelial corneal dystrophy	62
Optical coherence tomography angiography in diabetic retinopathy	61
Identification of novel biomarkers for retinopathy of prematurity in preterm infants by use of innovative technologies and artificial intelligence	60
Targeting inflammasomes and pyroptosis in retinal diseases—molecular mechanisms and future perspectives	59
Editorial Board	58
Rhodopsin, light-sensor of vision	58
Regulation of lens water content: Effects on the physiological optics of the lens	55
Interventions to Reduce Incidence and Progression of Myopia in Children and Adults	54
Female carriers of X-linked inherited retinal diseases – Genetics, diagnosis, and potential therapies	52
Genetic therapies and potential therapeutic applications of CRISPR activators in the eye	51
Retinal pigment epithelium 65 kDa protein (RPE65): An update	50
Pseudoxanthoma elasticum – Genetics, pathophysiology, and clinical presentation	49
Editorial Board	48
The retinal pigment epithelium: Development, injury responses, and regenerative potential in mammalian and non-mammalian systems	48
Pentosan polysulfate maculopathy: clinical considerations, pathobiology, and causality	48
Pluripotent stem cell-derived models of retinal disease: Elucidating pathogenesis, evaluating novel treatments, and estimating toxicity	47
The march to harmonized imaging standards for retinal imaging	46
Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)	45
Retinal TRP channels: Cell-type-specific regulators of retinal homeostasis and multimodal integration	44
Quantitative approaches in multimodal fundus imaging: State of the art and future perspectives	44
Bacterial keratitis: identifying the areas of clinical uncertainty	43
Activation of retinal glial cells contributes to the degeneration of ganglion cells in experimental glaucoma	42
The role of CFTR in the eye, and the effect of early highly effective modulator treatment for cystic fibrosis on eye health	41
Translocator protein (18 kDa) (Tspo) in the retina and implications for ocular diseases	40
Clinical histopathology and pathogenesis of macular telangiectasia type 2	39
Artificial intelligence in ophthalmology: Progress, challenges, and ethical implications	39